Compare · KRMD vs SYK
KRMD vs SYK
Side-by-side comparison of KORU Medical Systems Inc. (KRMD) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KRMD and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $120.38B, about 655.2x KRMD ($183.7M).
- Over the past year, KRMD is up 31.1% and SYK is down 17.8% - KRMD leads by 49.0 points.
- KRMD has been more active in the news (10 items in the past 4 weeks vs 8 for SYK).
- SYK has more recent analyst coverage (25 ratings vs 6 for KRMD).
- Company
- KORU Medical Systems Inc.
- Stryker Corporation
- Price
- $3.98-0.50%
- $313.99+4.11%
- Market cap
- $183.7M
- $120.38B
- 1M return
- -5.91%
- +9.97%
- 1Y return
- +31.14%
- -17.84%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 8
- Recent ratings
- 6
- 25
KORU Medical Systems Inc.
Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. It also provides education and training materials to clinicians, patients, and patient advocates. The company sells its products through direct sales and medical device distributors, as well as online. Repro Med Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest KRMD
- KORU Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Technology Officer Schiller Eric bought $19,562 worth of shares (5,000 units at $3.91) (SEC Form 4)
- Amendment: Chief Executive Officer Tharby Linda M bought $4,669 worth of shares (1,191 units at $3.92), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)
- Chief Executive Officer Tharby Linda M bought $1,418,481 worth of shares (1,191 units at $1,191.00), increasing direct ownership by 0.19% to 620,622 units (SEC Form 4)
- Chief Executive Officer Tharby Linda M converted options into 13,977 shares and covered exercise/tax liability with 7,326 shares, increasing direct ownership by 1% to 619,431 units (SEC Form 4) (for withholding tax)
- Chief Operating Officer Pazdan Christopher converted options into 5,327 shares and covered exercise/tax liability with 1,470 shares, increasing direct ownership by 1% to 308,988 units (SEC Form 4) to cover withholding tax
- Chief Operating Officer Pazdan Christopher bought $19,400 worth of shares (5,000 units at $3.88), increasing direct ownership by 2% to 305,131 units (SEC Form 4)
- Chief Financial Officer Adams Thomas Edward converted options into 8,193 shares and covered exercise/tax liability with 2,900 shares, increasing direct ownership by 2% to 313,440 units (SEC Form 4) to cover taxes
- Chief Financial Officer Adams Thomas Edward bought $21,248 worth of shares (5,500 units at $3.86), increasing direct ownership by 2% to 308,147 units (SEC Form 4)
- KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress
Latest SYK
- President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)
- Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
- VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)
- Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)
- Stryker Launches Pangea Plating System and Completes First Case in Europe
- SEC Form SD filed by Stryker Corporation
- SEC Form 8-K filed by Stryker Corporation
- BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem
- VP, Chief HR Officer Fink M Kathryn exercised 21,582 shares at a strike of $167.98, covered exercise/tax liability with 16,362 shares and sold $2,473,756 worth of shares (8,720 units at $283.69) (SEC Form 4)
- SEC Form 10-Q filed by Stryker Corporation